THE ARROVEN STUDY (MA25101): POST-AUTHORISATION OBSERVATIONAL SAFETY STUDY OF BRENTUXIMAB VEDOTIN IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA AND SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA

  • K. Linton
  • , R. Ayto
  • , F. d'Amore
  • , M. Moestl
  • , I. Chau
  • , S. Paneesha
  • , J. Kinley
  • , D. Huebner
  • , J. Porter
  • , B. Exter
  • , B. Wang
  • , J. Tymoszczuk
  • , A. Arumainathan

Research output: Contribution to journalArticlepeer-review

Cite this